*001619434
*00520190107202025.0
*007ta
*008161117s2016    no a   e m    00  0 eng
*00901015nam a2200265 c 4500
*019  $bl
*020  $a978-82-308-3212-7$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)999920190570602201
*035  $a(NO-LaBS)13502065(bibid)
*040  $aNO-OsNB$bnob$ekatreg
*060 4$aQZ 266
*08204$a616.994060724$223/nor$qNO-OsNB
*1001 $aFørde-Tislevoll, Hilde Elise$d1985-$0(NO-TrBIB)10046903$4aut$_91012400
*24510$aExperimental therapies in preclinical tumor models :$bvalidiating PI3K inhibitors and sulfasalazine in cancer treatment$cHilde Elise Førde-Tislevoll
*260  $a[Bergen]$bUniversity of Bergen$c2016
*300  $a1 b. (flere pag.)$bill. (noen kol.)$c24 cm
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Bergen, 2016
*650 2$aBrain Neoplasms$0D001932$_75512800
*650 2$aGlioblastoma$0D005909$_19034800
*650 2$aNeoplasms$0D009369$_22109500
*7102 $aUniversitetet i Bergen$bInstitutt for biomedisin$0(NO-TrBIB)10073621$4dgg$_12926500
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999919859991302202$b2021-11-14T20:36:22Z$z999919859991302202
^